ciprofloxacin has been researched along with quinoline in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caron, G; Ermondi, G | 1 |
| Chellan, P; Land, KM; Sadler, PJ | 1 |
| Aleixandre, V; Blanco, M; Herrera, G; Urios, A | 1 |
| Ida, S; Ohno, I | 1 |
| Chu, DT; Claiborne, AK; Fernandes, PB; Maleczka, RE; Nordeen, CW; Pernet, AG; Pihuleac, E | 1 |
| Albrecht, HA; Beskid, G; Christenson, JG; Deitcher, KH; Georgopapadakou, NH; Keith, DD; Konzelmann, FM; Pruess, DL; Wei, CC | 1 |
| Chowdhary, RA; Cook, PP; Rimawi, RH; Shah, KB | 1 |
| Cha, SY; Choi, SW; Jang, HK; Kang, M; Wei, B | 1 |
| Butaye, P; Cheng, D; Gong, J; Hathcock, T; Huang, K; Lu, G; Qiu, H; Wang, C; Zhang, J; Zhu, G | 1 |
3 review(s) available for ciprofloxacin and quinoline
| Article | Year |
|---|---|
Recent developments in drug discovery against the protozoal parasites Cryptosporidium and Toxoplasma.
Topics: Animals; Antiprotozoal Agents; Apoptosis; Cryptosporidiosis; Cryptosporidium; Diazepam Binding Inhibitor; Drug Discovery; Enzyme Inhibitors; Humans; Mice; Toxoplasma; Toxoplasmosis | 2017 |
[Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. b. Synthetic antibacterial agents].
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Ciprofloxacin; Drug Resistance, Microbial; Humans; Norfloxacin; Ofloxacin; Oxazines; Oxolinic Acid; Quinolines; Respiratory Tract Infections | 1987 |
Hunting for tularaemia - a review of cases in North Carolina.
Topics: Animals; Anti-Bacterial Agents; Bites and Stings; Cats; Ciprofloxacin; Francisella tularensis; Humans; Male; Middle Aged; North Carolina; Public Health; Quinolines; Tularemia; Zoonoses | 2015 |
6 other study(ies) available for ciprofloxacin and quinoline
| Article | Year |
|---|---|
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
Effects of ciprofloxacin on plasmid DNA supercoiling of Escherichia coli topoisomerase I and gyrase mutants.
Topics: Ciprofloxacin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA, Superhelical; Drug Resistance, Microbial; Escherichia coli; Mutation; Nucleic Acid Conformation; Plasmids; Quinolines | 1991 |
Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents.
Topics: Acinetobacter; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli; Female; Fluorine; Fluoroquinolones; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Piperazines; Pseudomonas aeruginosa; Quinolines; Staphylococcus; Streptococcus; Structure-Activity Relationship | 1985 |
Dual-action cephalosporins incorporating a 3'-tertiary-amine-linked quinolone.
Topics: beta-Lactamases; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Resistance, Microbial; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Structure; Nitrogen; Quinolines; Structure-Activity Relationship | 1994 |
Molecular Characterization of Fluoroquinolone Resistance Mechanisms of Campylobacter Isolates from Duck Meats.
Topics: Animals; Campylobacter; Campylobacter jejuni; Ciprofloxacin; DNA Gyrase; Drug Resistance, Bacterial; Ducks; Fluoroquinolones; Meat; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Quinolines; Quinolones | 2017 |
CRISPR/Cas9/sgRNA-mediated targeted gene modification confirms the cause-effect relationship between gyrA mutation and quinolone resistance in Escherichia coli.
Topics: Amino Acid Motifs; Animals; Anti-Bacterial Agents; Chickens; Ciprofloxacin; CRISPR-Cas Systems; DNA Gyrase; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Gene Editing; Microbial Sensitivity Tests; Mutation; Poultry Diseases; Quinolines; Quinolones; RNA, Bacterial; Swine; Swine Diseases | 2018 |